Home / Generics

Generics

News

US court puts generic Gralise on hold posted 02/09/2014

US specialty drugmaker Depomed has received a favourable preliminary verdict in its case against generics manufacturer Actavi...

Generics manufacturers focus on MS drug Ampyra posted 22/08/2014

Following news that Acorda Therapeutics (Acorda) was preparing to defend its intellectual property rights against a competito...

Actavis submits generic dalfampridine ANDA posted 08/08/2014

Acorda Therapeutics (Acorda), announced on 26 June 2014 that it had received a Paragraph IV Certification Notice Letter advis...

Generic valsartan approved in US posted 01/08/2014

India’s largest generics maker Ranbaxy Laboratories announced on 27 June 2014 that its subsidiary, US-based Ohm Laboratories...

Teva settles patent litigation over ProAir HFA posted 04/07/2014

The world’s biggest generics maker, Teva Pharmaceutical Industries (Teva), announced on 20 June 2014 that it had reached a se...

 

Research

Value of generics overlooked in one country that needs them most: Greece posted 29/08/2014

A study of physicians’ prescribing patterns and perceptions towards generics in Greece has revealed a clear need for an appro...

Trends in the financial burden of diabetes treatment posted 22/08/2014

The number of adults diagnosed with diabetes in the US increased 75% between 2000 and 2010, resulting in 9% of the adult popu...

Right of appeal provision in CETA posted 14/08/2014

The Comprehensive Economic and Trade Agreement (CETA) between the European Union (EU) and Canada has the potential to have a...

Data protection provisions in CETA posted 04/08/2014

The trade agreement between the European Union (EU) and Canada has the potential to have a negative affect on the generics in...

Patent term restoration provisions in CETA posted 01/08/2014

Some of the provisions included in the Comprehensive Economic and Trade Agreement (CETA) between the European Union (EU) and...

 

General

Lawyers look at new price hike for old drug posted 29/08/2014

Two generic drug companies are being investigated by the Connecticut Attorney General’s office following reports of alarming...

Ranbaxy’s manufacturing woes benefit big pharma posted 25/08/2014

Import bans by the US Food and Drug Administration (FDA) on generics from four of Ranbaxy Laboratories’ (Ranbaxy) manufacturi...

Recalls call into question metoprolol generics posted 08/08/2014

Recent recalls have vindicated a cardiologist’s warnings about generic versions of a widely used heart drug, Toprol XL (metop...

India planning to extend pricing control to more drugs posted 01/08/2014

India is thought likely to increase the number of drugs it considers ‘essential’ and therefore for which it controls the maxi...

European regulators give green light to Ranbaxy plant posted 13/06/2014

In what comes as good news for generics maker Ranbaxy, European Regulators have cleared the company’s Toansa plant.

Generics News Research General

more

Biosimilars News Research General

more